Perioral Tissue Evaluation With Advanced Videodermoscopy (FAV)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-35
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

The primary aim of this study is to characterize and systematically document the key dermato-mucosal structures of the perioral region in physiological conditions. Relative to the anterior chin area (ACA), the authors have tried to identify and describe pores, fine lines or wrinkles, texture patterns, superficial desquamation, hair follicles, sebaceous glands, fine ridges, grooves, sebaceous ducts, and skin irregularities. The observed features of the vermilion border (VB) and vermilion zone (VZ) include variations in color, texture, and surface characteristics, alongside the presence of fine lines and grooves. Vascular patterns and capillary visibility were observed, with pigmentation patterns providing additional insights into structural uniformity and non-uniform areas. Shiny surfaces, pore visibility, and regional differences in sebaceous activity and texture were also highlighted, reflecting the complex variability across the vermilion zone. Additionally, novel dermatoscopic and FAV findings not previously described in the literature were introduced into the analysis based on the personal observations of the investigators. This allowed for a comprehensive evaluation of the skin characteristics, providing a detailed analysis for each anatomical zone studied.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age: Participants must be between 20 and 35 years old

Health Status: Participants must be in good general health with no known systemic diseases (ASA I)

Skin Condition: Participants must have clinically healthy skin in the target area, with no history of dermatological conditions such as eczema, psoriasis, or dermatitis

Consent: Participants must provide written informed consent to participate in the study

Disqualifiers

Dermatological Disorders: History of skin diseases (e.g., acne, psoriasis, eczema) or other skin conditions that could interfere with the assessment

Chronic Illnesses: Presence of chronic systemic conditions (e.g., diabetes, autoimmune diseases) that may affect skin health

Medications: Current use of medications or treatments that could alter skin characteristics (e.g., corticosteroids, retinoids, immunosuppressants)

Allergies: Known allergies to topical products used during the examination

Trial population

For the evaluation of healthy perioral tissues, the target population consisted of young, healthy individuals. The survey population specifically included students enrolled in the Dentistry and Dental Hygiene degree programs at the Catholic University of the Sacred Heart in Rome.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Clinical evaluation of oral mucosa disease

To observed the anterior chin area (ACA), the authors have tried to identify and describe pores, fine lines or wrinkles, texture patterns, superficial desquamation, hair follicles, sebaceous glands, fine ridges, grooves, sebaceous ducts, and skin irregularities.

Time frame
8 weeks
2

Clinical evaluation of perioral mucosa

To observed the vermilion border (VB) and vermilion zone (VZ) include variations in color, texture, and surface characteristics, alongside the presence of fine lines and grooves. Vascular patterns and capillary visibility were observed, with pigmentation patterns providing additional insights into structural uniformity and non-uniform areas.

Time frame
8 weeks
3

Clinical evaluation of surface and texture of oral muocsa

To observed shiny surfaces, pore visibility, and regional differences in sebaceous activity and texture were also highlighted, reflecting the complex variability across the vermilion zone.

Time frame
8 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.